No Data
Earnings Preview: XRAY to Report Financial Results on February 27
DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock?
Analysts Have Conflicting Sentiments on These Healthcare Companies: Select Medical (SEM), DENTSPLY SIRONA (XRAY) and Neumora Therapeutics, Inc. (NMRA)
Wells Fargo Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $20
This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Wells Fargo Initiates Coverage on DENTSPLY SIRONA With Equal Weight Rating, $20 Price Target
DENTSPLY SIRONA (NASDAQ:XRAY) Shareholders Have Endured a 32% Loss From Investing in the Stock Three Years Ago
